FOUNDERS FINANCIAL SECURITIES LLC
Broker-DealerPosition in ABBV — AbbVie Inc.
CIK 1342396
TOWSON, MD
Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,466,575
+$1,402,614 QoQ
Shares Held
9,802
+100.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#1,794
of 4,152 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 7%
None 93%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FOUNDERS FINANCIAL SECURITIES LLC holds $21,446,689 across 11 Drug Manufacturers - General names. ABBV ranks #4 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
23,408 | $5,944,929 | |
| 2 | AMGN |
Amgen Inc
|
8,037 | $2,910,358 | |
| 3 | MRK |
Merck & Co., Inc.
|
19,290 | $2,478,765 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
9,802 | $2,466,575 | |
| 5 | AZN |
Astrazeneca PLC
|
12,714 | $2,410,828 | |
| 6 | LLY |
ELI LILLY & Co
|
1,169 | $1,402,133 | |
| 7 | GSK |
GSK plc
|
21,673 | $1,136,098 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,321 | $1,051,275 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,466,575 | 9,802 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $1,063,961 | 4,892 | Shares | Defined | 2026-04-17 | |
| 2025-12-31 | $1,311,989 | 5,742 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,055,822 | 4,560 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $939,237 | 5,060 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,048,857 | 5,006 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $767,841 | 4,321 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $876,416 | 4,438 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,057,077 | 6,163 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $831,104 | 4,564 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $754,858 | 4,871 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $598,923 | 4,018 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $492,572 | 3,656 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $543,292 | 3,409 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $572,099 | 3,540 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $523,016 | 3,897 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $547,240 | 3,573 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $583,596 | 3,600 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $479,451 | 3,541 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $387,792 | 3,595 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $385,679 | 3,424 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $364,593 | 3,369 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $438,029 | 4,088 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $214,858 | 2,453 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $495,612 | 5,048 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||